2021
DOI: 10.20892/j.issn.2095-3941.2020.0238
|View full text |Cite
|
Sign up to set email alerts
|

Epithelial-mesenchymal transition-related circular RNAs in lung carcinoma

Abstract: The epithelial-mesenchymal transition (EMT) is a highly complex phenotypic conversion during embryogenesis, and is important for metastasis, which contributes to tumor deterioration and poor prognoses of cancer patients. Lung carcinoma has a high tendency to develop the EMT. Circular RNAs (circRNAs) are involved in EMT-related cell invasion and metastasis in various types of cancers. Moreover, circRNAs have been found to be a link to EMT-related transcription factors and EMT-associated signaling pathways. This… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 69 publications
0
5
0
Order By: Relevance
“…The abnormal activation of cell cycle‐related proteins accelerates tumor progression, 23 and the occurrence of epithelial‐mesenchymal transition (EMT) and extracellular matrix (ECM) remodeling caused by MMPs are characteristics positively correlated with tumor invasion and metastasis 24–26 . CircABCA13 overexpressing obviously upregulated cyclin D1, cyclin D3, N‐cadherin, MMP‐2, and MMP‐9 and downregulated E‐cadherin (Figures 2J and S3E), while the opposite effects were observed in circABCA13 knockdown cells.…”
Section: Resultsmentioning
confidence: 99%
“…The abnormal activation of cell cycle‐related proteins accelerates tumor progression, 23 and the occurrence of epithelial‐mesenchymal transition (EMT) and extracellular matrix (ECM) remodeling caused by MMPs are characteristics positively correlated with tumor invasion and metastasis 24–26 . CircABCA13 overexpressing obviously upregulated cyclin D1, cyclin D3, N‐cadherin, MMP‐2, and MMP‐9 and downregulated E‐cadherin (Figures 2J and S3E), while the opposite effects were observed in circABCA13 knockdown cells.…”
Section: Resultsmentioning
confidence: 99%
“…During this process, which is considered a trigger of cancer metastasis, epithelial cells lose their polarity and differentiated state, and acquire a mesenchymal-like phenotype. Some circRNAs have been found to act as competing endogenous RNAs (ceRNAs) for miRs involved in EMT signaling pathways, thus leading to tumor progression 57 , although the underlying mechanisms are uncertain. In this review, we dissect the roles of signaling pathways in malignant carcinomas, focusing on molecular mechanisms and prospects for future intervention ( Table 1 ).…”
Section: Multiple Signaling Pathways Of Circrnas In Cancersmentioning
confidence: 99%
“…In addition to Hippo/yap, nuclear factor-kappa B (NF-κB), janus kinases/signal transducer and activator of transcription proteins (JAK/STAT), mitogen-activated protein kinases (MAPK), and phosphatidylinositol 3-kinase (PI3K)/Akt/ mechanistic target of rapamycin (mTOR), investigations on each of these pathways have been the subject of new developments in the last 3 years and are reviewed below. Meanwhile, the role of potential additional factors that drive EMT in cancer (Figure 2) was also highlighted, namely transcriptional factors (TFs) (Vishnoi et al, 2020), translation initiation mechanisms (Bera and Lewis, 2020), miRNAs (Pan et al, 2021) and circular RNAs (circRNAs) (Jiang M. et al, 2021), hypoxia (Peng P. H. et al, 2021), inflammation (Chattopadhyay et al, 2021, and stromal components like tumor-associated macrophages (TAMs) (Han et al, 2021) and cancer-associated fibroblasts (CAFs) (Asif et al, 2021). Other emerging or developing research fields were represented by cancer-associated adipocytes (Liu et al, 2020), endothelial cells and their transformation via endothelial-tomesenchymal transition (EndMT) (Yoshimatsu and Watabe, 2022), and vascular mimicry (Sun et al, 2017).…”
Section: Overview Of Emt Driving Parameters In Cancer An Updatementioning
confidence: 99%